Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
Figure 4
Combination of the prognostic information of GE-based risk score and NRIP1 and TCF7 gene expression. (a) Kaplan-Meier analyses were performed to combine the prognostic information of GE-based risk score and NRIP1 and TCF7 gene expression. Patients were scored from 1 to 5 according to GE-based risk score in and groups. (b) After merging consecutive groups with no prognostic difference, 3 patient groups with different overall survival (OS) were obtained: I, II, and III (patients of the training cohort, ).
